What Key Growth Drivers Are Shaping The Digital Therapeutics Sarcopenia Market Forecast Toward $2.77 Billion?
Uncover key drivers, emerging technologies, and competitive movements shaping the digital therapeutics sarcopenia market from 2025–2034 with trusted insights from The Business Research Company
How Big Is The Digital Therapeutics Sarcopenia Market Today And What Is Its Future Size?
The digital therapeutics sarcopenia market size has expanded rapidly over recent years. It is anticipated to grow from $1.32 billion in 2024 to $1.54 billion in 2025, achieving a compound annual growth rate (CAGR) of 16.3%. This historical expansion can be attributed to a rising aging population, the increasing prevalence of age-related muscle loss, enhanced awareness of sarcopenia, greater adoption of telehealth, a growing demand for home-based rehabilitation, and supportive government initiatives aimed at digital healthcare.
The digital therapeutics sarcopenia market size is anticipated to experience significant expansion in the coming years. This market is projected to reach $2.78 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 16.0%. This projected growth stems from several factors, including an increasing elderly demographic, a heightened emphasis on maintaining muscle health proactively, greater incorporation of Artificial intelligence into digital therapeutics, broader reimbursement frameworks for DTx, the creation of tailored exercise regimens, increased collaborations between technology companies and healthcare service providers, and a surging need for remote rehabilitation options. Key trends anticipated during this period encompass progress in AI-powered customized exercise solutions, seamless integration with wearable health monitoring devices, the proliferation of tele-rehabilitation platforms, their increasing use within elderly care settings, improved capabilities for remote patient monitoring, and innovations across various digital health solutions.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27278&type=smp
Which Demand Drivers Are Strengthening The Digital Therapeutics Sarcopenia Market?
The increasing occurrence of comorbidities is anticipated to propel the expansion of the digital therapeutics sarcopenia market. Comorbidities describe the simultaneous presence of two or more health conditions in the same individual. The rise in comorbidities is attributed to an aging population, as advancing age heightens the probability of developing multiple chronic conditions due to declining physiological function and long-term exposure to health risks. Digital therapeutics for sarcopenia prove advantageous in preventing comorbidities, especially obesity, by promoting consistent physical activity and muscle strengthening, which helps enhance metabolism and reduce fat accumulation. For instance, in March 2024, the World Obesity Federation, a UK-based membership organization, reported that nearly 79% of adults affected by overweight and obesity are expected to be living in low- and middle-income nations by 2035, with the total number of adults with obesity projected to reach 1.53 billion. Therefore, the growing prevalence of comorbidities is driving the growth of the digital therapeutics sarcopenia market.
Which Segment Accounts For The Largest Share In The Digital Therapeutics Sarcopenia Market?
The digital therapeutics sarcopenia market covered in this report is segmented
1) By Product: Software, Devices, Services
2) By Distribution Channel: Online Platforms, Pharmacies, Other Distribution Channels
3) By Application: Muscle Strengthening, Physical Activity Monitoring, Nutrition Management, Other Applications
4) By End User: Hospitals And Clinics, Homecare Settings, Rehabilitation Centers, Other End Users
Subsegments:
1) By Software: Mobile Applications, Web-Based Platforms, AI-Powered Monitoring Tools, Exercise And Rehabilitation Programs, Nutritional Guidance Software
2) By Devices: Wearable Fitness Trackers, Smart Scales, Connected Resistance Bands, Electromyography (EMG) Devices, Muscle Strength Assessment Tools
3) By Services: Remote Patient Monitoring Services, Virtual Physiotherapy Sessions, Teleconsultation Services, Personalized Coaching Services, Data Analytics And Reporting Services
Which Long-Term Trends Will Play A Crucial Role In The Digital Therapeutics Sarcopenia Market?
Companies actively engaged in the digital therapeutics sarcopenia market are focusing on developing advanced solutions, such as drug discovery platforms, with the goal of creating more targeted treatments, enhancing the effectiveness of therapies, and accelerating the delivery of personalized care for age-related muscle loss. A drug discovery platform aids in the faster and more efficient identification and creation of new drugs by utilizing advanced tools and methodologies. For instance, in April 2025, ProFuse Technology, an Israel-based biotechnology company, unveiled a new drug discovery platform specifically designed to prevent muscle loss caused by GLP-1 weight-loss drugs, aging (sarcopenia), and cancer cachexia. By using lab-grown, highly mature muscle tissues that accurately mimic natural muscle, the company can test and screen drug candidates more precisely, quickly, and efficiently. This advanced platform reduces dependence on animal testing and lowers research costs. As the demand for muscle-preserving therapies grows, ProFuse is expanding its focus from cultivated meat into biopharma, offering a groundbreaking method to address increasing muscle health challenges.
Which Companies Hold A Competitive Edge In The 83 Market?
Major companies operating in the digital therapeutics sarcopenia market are Noom Inc., Sword Health Inc., Biofourmis Inc., Hinge Health Inc., Omada Health Inc., Virta Health Corp., Evolv Rehabilitation Technologies Ltd., Click Therapeutics Inc., DarioHealth Corp., WellDoc Inc., Propeller Health, Lark Technologies Inc., mySugr GmbH, SilverCloud Health Limited (a part of Amwell), Kaia Health Software GmbH, Liva Healthcare A/S, Zibrio Inc., Gait Up SA, Noraxon Inc., Mira Rehab Limited, and Cometa Srl.
Access The Complete Report Here:
Which Region Is Forecasted To Lead The Digital Therapeutics Sarcopenia Market In The Coming Years?
North America was the largest region in the digital therapeutics sarcopenia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics sarcopenia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=27278&type=smp
Browse Through More Reports Similar to the Global Digital Therapeutics Sarcopenia Market 2025, By The Business Research Company
Lithium Ion Battery Binders Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/lithium-ion-battery-binders-global-market-report
Battery Manufacturing Equipment Global Market Report 2025
Battery Separators Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/battery-separators-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
